Procter & Gamble Awards Health Care CEO 12,517 Restricted Stock Units
Procter & Gamble's CEO of Health Care, Paul Gama, received a significant award of 12,517 restricted stock units on October 1, 2026. This award was granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Following this award, Gama's direct holdings in common stock increased to 53,349 shares.
In addition to his direct holdings, Gama also holds 1,173 common shares indirectly through the Retirement Plan Trustee. This indirect holding is part of a separate position listed in the report. The restricted stock units awarded to Gama are subject to certain conditions, such as meeting specific time-based requirements before they fully vest.
The award highlights Procter & Gamble's strategy to incentivize its executives through stock-based compensation. Restricted stock units are a common method used by companies to align the interests of executives with those of shareholders, providing a direct stake in the company's performance.